Rabeprazole sodium and Naprosyn drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rabeprazole sodium (rabeprazole sodium) and Naprosyn (naproxen). Common drug interactions include obesity among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Rabeprazole sodium and Naprosyn. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.
What is Rabeprazole sodium?
Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.
What is Naprosyn?
Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
45 people who take Rabeprazole sodium and Naprosyn together, and have interactions are studied.

What are the common drug interactions of Rabeprazole Sodium and Naprosyn, by gender? *:
female:
- Obesity (having too much body fat)
- Stress
- Swelling
- C-reactive protein increased
- Hypersensitivity
- Joint swelling
- Therapeutic response decreased (less preventive response)
- Drug effect decreased
- Application site rash
- Intervertebral disc protrusion (spinal disc protrusion)
male:
- Anaemia (lack of blood)
- Anxiety
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Decreased interest
- Dental caries
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
- Dysphemia (stammering or stuttering)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the common drug interactions of Rabeprazole Sodium and Naprosyn, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Contusion (a type of hematoma of tissue in which capillaries)
- Haemorrhage (bleeding)
- Hydronephrosis (water inside the kidney)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Malaise (a feeling of general discomfort or uneasiness)
- Urinary tract infection
50-59:
- Blood phosphorus decreased
- Cardiac arrest
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Dehydration (dryness resulting from the removal of water)
- Denervation atrophy (interruption of the nerve connection to an organ waste away)
- Ejection fraction decreased (systolic heart failure)
- Fall
- Herpes simplex (herpes simplex is a common viral infection)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
60+:
- Pain in extremity
- Abdominal distension
- Joint swelling
- Limb injury
- Malaise (a feeling of general discomfort or uneasiness)
- Muscle spasms (muscle contraction)
- Oedema peripheral (superficial swelling)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Oxygen saturation decreased
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 53.33%
- Joint Pain: 16 people, 35.56%
- Tendon Disorder (disease of tendon): 3 people, 6.67%
- Indigestion: 3 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Rabeprazole sodium and Naprosyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rabeprazole sodium (15,786 reports)
- Naprosyn (16,738 reports)
Browse all drug interactions of Rabeprazole sodium and Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rabeprazole sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rabeprazole sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naprosyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and naproxen (the active ingredients of Rabeprazole sodium and Naprosyn, respectively), and Rabeprazole sodium and Naprosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Alendronate Sodium cause Peripheral Embolism? - now
- Crestor and Blood Pressure Decreased for Men aged 60+ - 6 seconds ago
- Abscess and Infusion Related Reaction - 6 seconds ago
- Crestor and Low Blood Pressure for Men aged 60+ - 7 seconds ago
- Crestor and Hypotension for Men aged 60+ - 7 seconds ago
- Could Prozac cause Adrenal Adenoma? - 11 seconds ago
- Could Folic Acid cause Vulvovaginal Burning Sensation? - 12 seconds ago
- Could Escitalopram cause Weight Loss? - 17 seconds ago
- Could Kaletra cause Hepatic Lesion? - 28 seconds ago
- Abdominal Discomfort and Broken Bone - 29 seconds ago